UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
Current Report Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): January 13, 2014
AMERILITHIUM CORP.
(Exact name of registrant as specified in its charter)
Nevada | 333-155059 | 61-1604254 |
(State or other jurisdiction of incorporation) | (Commission File Number) | (I.R.S. Employer Identification Number) |
871 Coronado Center Drive, Suite 200
Henderson, NV 89052
(Address of principal executive offices)
(702) 583-7790
(Registrants telephone number, including area code)
[ ] Written communication pursuant to Rule 425 under the Securities Act (17 CFR 230.425) [ ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) [ ] Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) [ ] Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 40.13e-4(c)) |
Item 4.02 Non-Reliance on Previously Issued Financial Statements or a Related Audit Report or Completed Interim Review.
Subsequent to the original filing of Amerilithium Corps (the Company) Form 10-Q for the period ending September 30, 2013, the Company brought to the attention of its independent registered public accounting firm a potential misstatement in the Companys financial statements contained in its quarterly reports for the third quarter of 2013. On January 13, 2014, the Companys board of directors (the Board) and chief executive officer, after consultation with Companys independent registered public accounting firm, concluded that the unaudited financial statements for the period ended September 30, 2013, filed in a quarterly report on Form 10-Q with the Securities and Exchange Commission (the SEC) on November 19, 2013, contained material misstatements pertaining to the accounting treatment with respect to the recording of certain convertible promissory notes issued by the Company.
The following tables represent the effects of the restated statements for the quarter ended September 30, 2013:
Balance Sheet |
|
|
|
|
|
|
|
| September 30, 2013 As Filed |
| Adjustments |
| September 30, 2013 (Restated) |
LIABILITIES AND STOCKHOLDERS' DEFICIT |
|
|
|
|
|
|
Convertible notes net of discount-current | $ | 170,480 | $ | 207,532 | $ | 378,012 |
Total current liabilities | $ | 274,690 | $ | 207,532 | $ | 482,222 |
Total liabilities | $ | 327,482 | $ | 207,532 | $ | 535,014 |
218,380,512 and 117,458,776 shares issued and outstanding | $ | 212,381 | $ | 6,000 | $ | 218,381 |
Additional paid-in capital | $ | 11,127,847 | $ | 21,789 | $ | 11,149,636 |
Stock payable | $ | 27,884 | $ | (27,789) | $ | 95 |
Accumulated deficit during the development stage | $ | (8,140,715) | $ | (207,532) | $ | (8,348,247) |
Total stockholders equity | $ | 3,227,397 | $ | (207,532) | $ | 3,019,865 |
Statements of Operations for the Three Months ended September 30, 2013:
|
| Three months ended September 30, 2013 As Filed |
| Adjustments |
| Three months ended September 30, 2013 (Restated) |
Professional fees | $ | 64,984 | $ | 75,000 | $ | 139,984 |
Total operating expense | $ | 1,750,152 | $ | 75,000 | $ | 1,825,152 |
Loss from operations | $ | (1,750,152) | $ | (75,000) | $ | (1,825,152) |
Interest expense | $ | 42,672 | $ | (217,876) | $ | (175,204) |
Total other expenses | $ | 42,672 | $ | (217,876) | $ | (175,204) |
Net loss | $ | (1,707,480) | $ | (292,876) | $ | (2,000,356) |
Statements of Operations for the Nine Months ended September 30, 2013:
| Nine months ended September 30, 2013 As Filed |
| Adjustments |
| Nine months ended September 30, 2013 (Restated) | |
Professional fees | $ | 221,719 | $ | 75,000 | $ | 296,719 |
Total operating expense | $ | 2,079,522 | $ | 75,000 | $ | 2,154,522 |
Loss from operations | $ | (2,079,522) | $ | (75,000) | $ | (2,154,522) |
Interest expense | $ | 248,601 | $ | 132,532 | $ | 381,133 |
Total other expenses | $ | 248,601 | $ | 132,532 | $ | 381,133 |
Net loss | $ | (2,328,123) | $ | (207,532) | $ | (2,535,655) |
Statement of Operations from inception (February 2, 2004) through September 30, 2013:
| From inception (February 2, 2004) through September 30, 2013 As filed |
| Adjustments |
| From inception (February 2, 2004) through September 30, 2013 (Restated) | |
Professional fees | $ | 1,347,370 | $ | 75,000 | $ | 1,422,370 |
Total operating expense | $ | 7,034,622 | $ | 75,000 | $ | 7,109,622 |
Loss from operations | $ | (7,034,622) | $ | (75,000) | $ | (7,109,622) |
Interest expense | $ | 1,106,093 | $ | 132,532 | $ | 1,238,625 |
Total other expenses | $ | 1,106,093 | $ | 132,532 | $ | 1,238,625 |
Net loss | $ | (8,140,715) | $ | (207,532) | $ | (8,348,247) |
Statements of Cash Flows for the Nine Months Ended September 30, 2013:
|
| Nine months ended September 30, 2013 As Filed |
| Adjustments |
| Nine months ended September 30, 2013 (Restated) |
Net loss | $ | (2,328,123) | $ | (207,532) | $ | (2,535,655) |
Professional fees settled with convertible notes payable | $ | - | $ | 75,000 | $ | 75,000 |
Amortization of debt discount | $ | 119,420 | $ | 132,532 | $ | 251,952 |
Statement of Cash Flows from inception (February 2, 2004) through September 30, 2013:
|
| From inception (February 2, 2004) through September 30, 2013 As filed |
| Adjustments |
| From inception (February 2, 2004) through September 30, 2013 (Restated) |
Net loss | $ | (8,140,715) | $ | (207,532) | $ | (8,348,247) |
Shares issued for services | $ | 591,357 | $ | (100) | $ | 591,257 |
Professional fees settled with convertible notes payable | $ | - | $ | 75,000 | $ | 75,000 |
Amortization of debt discount | $ | (170,863) | $ | 133,594 | $ | (37,269) |
Depreciation and amortization | $ | 5,203 | $ | (962) | $ | 4,241 |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this Current Report to be signed on its behalf by the undersigned hereunto duly authorized.
|
|
| AMERILITHIUM CORP. | ||
|
|
|
|
|
|
|
|
|
|
|
|
Dated: January 21, 2014 |
| By: | /s/ Matthew Worrall |
| |
|
|
|
| Name: Matthew Worrall |
|
|
|
|
| Title: Chief Executive Officer |
|